Compare BioNano Genomics Inc (BNGO) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Vanguard High Dividend Yield ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Vanguard High Dividend Yield ETF trades at $166.8. The key difference: Vanguard High Dividend Yield ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | VYM | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | — |
52-Week High | $4.92 | $166.14 |
52-Week Low | $1.06 | $136.63 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
VYM trades at $166.67, up 0.37% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF is highlighted in recent news for retirement income strategies, with a dividend of $0.98 scheduled for June 2026. It has shown strong performance, reaching new highs, though some articles note long-term underperformance versus the S&P 500.
The outlook is positive for income-focused investors due to its high-dividend yield and diversification, but risks include potential yield compression and market volatility. Analyst sentiment is mixed, with some advocating for its value exposure while others caution on growth limitations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
